Correlation Between Isocitrate Dehydrogenase Gene Aberrations and Prognosis of Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Correlation Between Isocitrate Dehydrogenase Gene Aberrations and Prognosis of Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Published:2017-02-28 Issue:15 Volume:23 Page:4511-4522
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Xu Qingyu,Li Yan,Lv Na,Jing Yu,Xu Yihan,Li Yuyan,Li Wenjun,Yao Zilong,Chen Xiaosu,Huang Sai,Wang Lili,Li Yonghui,Yu Li

Funder

National Natural Science Foundation of China

Capital Medical Development Scientific Research

Beijing Natural Science Foundation

National Public Health Grant Research Foundation

Capital of the Public Health Project

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT;Bone Marrow Transplantation;2024-08-14

2. Analysis of IDH and EGFR as biomarkers in glioblastoma multiforme: A case-control study;Heliyon;2024-08

3. Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study;Blood Science;2024-06-20

4. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors;Current Treatment Options in Oncology;2024-05-02

5. Isocitrate Dehydrogenase (IDH) 1 and 2 Mutations Predicts Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: a study of the ALWP of the EBMT;2024-04-09